| |||||||||
Type Mutant Stock; Targeted Mutation; Additional information on Genetically Engineered Mutant Mice. Species laboratory mouse Generation ?+F2p Donating Investigator Daniel Tenen, Beth Israel Deaconess Medical Center Description
Mice that are homozygous for the targeted mutation are viable, normal in size, and do not display any gross physical or behavioral abnormalities. Endogenous protein expression is unaffected by the loxP sequences flanking an upstream regulatory region (URE). When bred to mice with a cre recombinase gene under the control of a promoter of interest, the URE of the targeted gene is deleted in the tissue of interest. Deletion of this "floxed" URE may be useful in studying T cell lymphoma, AML and other cancers, as well as transcription factors, hematopoiesis, and development of multiple cell lineages.
| Control | ||
|---|---|---|
| 101043 B6129SF1/J | (approximate) | |
| 101045 B6129SF2/J | (approximate) | |
| Considerations for Choosing Controls | ||
Strains carrying other alleles of Sfpi1
006922 B6.Cg-Sfpi1tm2Dgt/J 006147 B6;FVB-Tg(Sfpi1,-EGFP)7Dgt/J 006083 STOCK Sfpi1tm1.3Dgt/J View Strains carrying other alleles of Sfpi1 (3 strains)
Cre-lox Systems
View Mammalian Phenotype Terms
Mammalian Phenotype Terms
assigned by genotype
Sfpi1tm1.2Dgt/Sfpi1tm1.2Dgt
involves: 129/Sv * 129S1/Sv * 129X1/SvJ * C57BL/6
- no phenotypic analysis
- *normal* no phenotypic analysis (MGI Ref ID J:90331)
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:
Cancer Research
Genes Regulating Growth and Proliferation
Increased Tumor Incidence (Leukemia: lymphatic)
Increased Tumor Incidence (Lymphomas)
Developmental Biology Research
Internal/Organ Defects (Lymphoid Tissue Defects)
Internal/Organ Defects (hematopoietic defects)
Lymphoid Tissue Defects (hematopoietic defects)
Hematological Research
Hematopoietic Defects
Immunology and Inflammation Research
Lymphoid Tissue Defects (hematopoietic development)
Internal/Organ Research
Lymphoid Tissue Defects
Research Tools
Cancer Research (Leukemia)
Cancer Research (tumor immunology)
Cre-lox System (loxP-flanked Sequences)
Hematological Research
Immunology and Inflammation Research
| Allele Symbol | Sfpi1tm1.2Dgt | ||
|---|---|---|---|
| Allele Name | targeted mutation 1.2, Daniel G Tenen | ||
| Allele Type | Targeted (Floxed/Frt) | ||
| Common Name(s) | -14kb UREloxP (neo-); URE floxed (neo-); | ||
| Strain of Origin | (129X1/SvJ x 129S1/Sv)F1-Kitl<+> | ||
| ES Cell Line Name | R1 | ||
| ES Cell Line Strain | (129X1/SvJ x 129S1/Sv)F1-Kitl<+> | ||
| Gene Symbol and Name | Sfpi1, SFFV proviral integration 1 | ||
| Chromosome | 2 | ||
| Gene Common Name(s) | Dis-1; OF; PU.1; SPI-1; SPI-A; Sfpi-1; Tcfpu1; Tfpu.1; transcription factor PU.1; | ||
| General Note | Crossing mice bearing this "floxed" allele with mice expressing Cre recombinase under control of a selected promoter will result in excision of the URE in the cell/tissue type of interest. | ||
| Molecular Note | This allele was generated by crossing mice bearing Sfpi1tm1Dgt with mice ubiquitously expressing FLP recombinase to produce progeny in which the FRT-flanked PGKneo cassette has been deleted. This leaves a single FRT site immediately upstream of the 5' member of a pair of loxP sites flanking the 3.4-kb upstream regulatory element (URE) that is located 14 kb upstream of the endogenous gene. Expression of the protein is unaffected by presence of the FRT or loxP sites. [MGI Ref ID J:106788] [MGI Ref ID J:90331] | ||
Genotyping Protocols
Sfpi1tm1.2Dgt, STD PCR, vers. 1
Helpful Links
Optimizing PCR Protocols
Rosenbauer F; Wagner K; Kutok JL; Iwasaki H; Le Beau MM; Okuno Y; Akashi K; Fiering S; Tenen DG. 2004. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat Genet 36(6):624-30. [PubMed: 15146183] [MGI Ref ID J:90331]
Sfpi1tm1.2Dgt relatedZhang P. 2006. Sfpi1<tm1.2> (URE loxP [neo-]) development Personal Communication :. [MGI Ref ID J:106788]
Colony Maintenance
Breeding & Husbandry When maintaining a live colony, these mice are bred as homozygotes.
| Pricing for USA, Canada and Mexico shipping destinations |
|
*Price(s) in US dollars ($)
Weeks of Age Price* Gender Cryorecovery Fee $1900.00 Cryopreserved Embryos Fee $1600.00
| Pricing for International shipping destinations |
|
*Price(s) in US dollars ($)
Weeks of Age Price* Gender Cryorecovery Fee $2470.00 Cryopreserved Embryos Fee $2080.00
| Standard Supply | Repository-Cryopreserved. Must Be Recovered. Please refer to pricing and supply notes for further information. |
|---|---|
| Supply Notes |
|
| Control | ||
|---|---|---|
| 101043 B6129SF1/J | (approximate) | |
| 101045 B6129SF2/J | (approximate) | |
| Considerations for Choosing Controls | ||
| USA, Canada and Mexico - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| International - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form
For additional Licensing and Use Restrictions view the link(s) below:
- Use of MICE by companies or for-profit entities requires a license prior to shipping.
- Use of MICE by companies or for-profit entities requires a license.
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. THE LABORATORY EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of MICE, products or services, The Jackson Laboratory will, at its option, provide credit or replacement for the MICE or product received or the services provided.
In no event shall The Jackson Laboratory, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, products or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of The Jackson Laboratory, its agents or employees. In purchasing or receiving MICE, products or services from The Jackson Laboratory, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges The Jackson Laboratory from all such causes of action or damages, and further agrees to defend and indemnify The Jackson Laboratory from any costs or damages arising out of any third party claims.
MICE and biological materials are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to The Jackson Laboratory’s MICE, products and services. In addition, special terms and conditions of sale of certain MICE, products and services may be set forth separately in The Jackson Laboratory web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, products and services by The Jackson Laboratory, and by its licensees and distributors.
Acceptance of delivery of MICE, products or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on The Jackson Laboratory, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, products services by The Jackson Laboratory.